ADK
LIVE

Serial Number

79170253

Owner

BIOCARTIS NV

Attorney

Thomas J. Mango

Filing Date

May 22, 2015

Add to watchlist:

No watchlists yet
View on USPTO

ADK Trademark

Serial Number: 79170253 • Registration: 5010060

ADK is a trademark filed by BIOCARTIS NV on May 22, 2015. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

BIOCARTIS NV (2 trademarks)

Generaal De Wittelaan 11 B3
Mechelen B-2800 , BE

Entity Type: 99

Trademark Details

Filing Date

May 22, 2015

Registration Date

August 2, 2016

Published for Opposition

May 17, 2016

Goods & Services

Computer software for the development of computer code for running assays and for processing of data related to assays in the fields of clinical [ and/or industrial ] diagnosis; computer software for medical research and data analysis; scientific and diagnostic apparatus and instruments, namely, computer software to assist in the development, running and analysis of assays, not for medical purposes, and computer software for analysing, displaying and visualizing experimental data, biological data and data from amplified analytes related to assays; computer software for the analysis of data processed from scientific apparatus, instruments and diagnostic apparatus, namely, molecular diagnostic system comprised of an electronic computer, cartridges and mechanical manipulation machine to operate the cartridge for the detection and quantification of nucleic acids, [ proteins, ] infectious agents and/or pathogens; computer software for remote handling of a scientific apparatus, instruments and diagnostic apparatus, namely, molecular diagnostic system comprised of an electronic computer, cartridges and mechanical manipulation machine to operate the cartridge for the detection and quantification of nucleic acids, proteins, infectious agents and/or pathogens in the field of diagnostics, clinical [ and/or industrial ] applications; all these aforementioned goods alone or in combination in use in the analysis and/or study phases of sampling or for use in the field of diagnostics

Compiling of information into computer databases and computerized word processing of data in the field of diagnostics, clinical [ and/or industrial ] applications; systemization of information in the nature of data and technical documentation into computer databases; updating and maintenance of information in the nature of data and technical documentation into computer databases; all these aforementioned services for use in the field of diagnostics, clinical [ and/or industrial ] applications

Scientific research for medical purposes, and scientific and technical analysis, in the fields of life sciences, diagnostics and medicine; chemical and biological analysis; chemistry services, namely, DNA, RNA and molecular analysis and screening services for scientific research and medical purposes; consultancy and advice relating to scientific research and development; design and development of medical diagnostic assay; development, design, installation, maintenance and updating of computer software in the field of diagnostics, clinical [ and/or industrial ] applications; installation, maintenance, and updating of computer software for a molecular diagnostic system for detection and quantification of nucleic acids, [ proteins, ] infectious agents and/or pathogens

Filing History

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Aug 2, 2025 REM4
INTERNATIONAL REGISTRATION RENEWED
May 22, 2025 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Jun 2, 2024 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
May 2, 2024 INPS
INVALIDATION PROCESSED
May 2, 2024 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 23, 2024 INPR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Feb 27, 2024 LIMN
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
Jan 1, 2024 RHRD
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Aug 23, 2023 NA71
REGISTERED-SEC.71 ACCEPTED
Aug 23, 2023 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 23, 2023 APRE
TEAS SECTION 71 RECEIVED
Feb 1, 2023 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 2, 2021 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jul 16, 2021 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 31, 2020 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 20, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 29, 2016 FICS
FINAL DISPOSITION PROCESSED
Dec 29, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 2, 2016 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Sep 1, 2016 NREP
REGISTERED-PRINCIPAL REGISTER
Aug 2, 2016 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 2, 2016 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 17, 2016 NPUB
PUBLISHED FOR OPPOSITION
May 17, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 27, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 27, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 27, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 13, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2016 CNSA
ASSIGNED TO EXAMINER
Mar 24, 2016 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2016 CRFA
ASSIGNED TO LIE
Feb 22, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 16, 2016 TROA
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Feb 11, 2016 CREV
CORRECTION TRANSACTION RECEIVED FROM IB
Jan 21, 2016 CRCV
REFUSAL PROCESSED BY IB
Sep 25, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 4, 2015 RFCS
REFUSAL PROCESSED BY MPU
Sep 4, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 4, 2015 RFCR
NON-FINAL ACTION WRITTEN
Sep 3, 2015 CNRT
ASSIGNED TO EXAMINER
Sep 3, 2015 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 12, 2015 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 6, 2015 REPR